Heart Failure Pharmacology
Sort by:
Top Ten Topics in Clinical Cardiology 2022
Panel Discussion: Genetic Testing and Lipid Management
- 31 views
- November 21, 2022
Top Ten Topics in Clinical Cardiology 2022
Clinical Relevance of Genetic Testing in Cardiovascular Diseases
FEATURING
Jessica Wang
- 136 views
- November 21, 2022
- 1
AHA 2022 Conference Coverage
AHA 2022: Torsemide Comparison With Furosemide for Management of Heart Failure - TRANSFORM-HF Trial
FEATURING
Robert Mentz
- 7,468 views
- November 21, 2022
- 27
AHA 2022 Conference Coverage
AHA 2022: Mineralocorticoid Receptor Antagonists in Patients With Atrial Fibrillation
FEATURING
Alireza Oraii
- 691 views
- November 21, 2022
- 3
CVRx | Barostim
Baroreflex Activation Therapy: A Novel Approach for HFrEF Patients HFSA Symposium 2022 Discussion
- 120 views
- November 16, 2022
CVRx | Barostim
Baroreflex Activation Therapy (BAT) - How Does it Work?
FEATURING
Marat Fudim
- 454 views
- November 16, 2022
- 2
Morristown Medical Center Cardiology & Heart Surgery
Hypertrophic Cardiomyopathy: Focus on Medical Advances and Athletic Participation
FEATURING
Matthew Martinez
- 81 views
- November 15, 2022
Houston Methodist DeBakey Heart and Vascular Center
Top 4 Topics in Preventive Cardiology: Discussion
- 37 views
- November 15, 2022
University of California, Irvine (UCI) Health 14th Annual Orange County Symposium for Cardiovascular Disease Prevention
Prevention of Heart Failure: New 2022 Guidelines
FEATURING
Andy Lee
- 2,529 views
- November 15, 2022
- 6
AHA 2022 Conference Coverage
AHA 2022: Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction
FEATURING
Pieter Martens
- 1,700 views
- November 14, 2022
- 11
UCLA Health
Fetal Congestive Heart Failure: Cardiomyopathy, Valvar Regurgitation, Arrhythmia, Ductal Constriction
FEATURING
Mark Sklansky
- 173 views
- November 14, 2022
- 2
Cedars Sinai
Durable MCS for Destination Therapy - Keeping Our Eyes on the Prize
FEATURING
Michelle Kittleson
- 520 views
- November 14, 2022
- 4
MUSC Cardiology
SGLT2 Inhibitors in HFpEF: Sifting Through Murky Data
FEATURING
Daniel Silverman
- 902 views
- November 9, 2022
- 5
MUSC Cardiology
Volume Management in the CardioRenal Syndrome
FEATURING
Harold Szerlip
- 648 views
- November 9, 2022
- 2
MUSC Cardiology
Water From a Stone: Overcoming Diuretic Resistance in HFpEF
FEATURING
Brian Houston
- 747 views
- November 8, 2022
- 8
MUSC Cardiology
The Underappreciated Problem of Sarcopenia and Frailty in HFpEF: Can It Be Treated?
FEATURING
Amanda Vest
- 40 views
- November 8, 2022
MUSC Cardiology
Social Determinants of Health Influence the Risk of HFpEF and Clinical Management
FEATURING
Alanna Morris
- 21 views
- November 8, 2022
MUSC Cardiology
Exercise and Diet as Therapy for Heart Failure with Preserved Ejection Fraction
FEATURING
Dalane Kitzman
- 474 views
- November 8, 2022
- 3
MUSC Cardiology
Guideline Recommendations for HFpEF
FEATURING
Biykem Bozkurt
- 1,190 views
- November 8, 2022
- 2
MUSC Cardiology
Preload Insufficiency: How Should It Be Diagnosed and Treated?
FEATURING
Ryan Tedford
- 682 views
- November 8, 2022
- 8
MUSC Cardiology
Inotropic Treatment for HFpEF? An Idea So Crazy It Just Might Be Right
FEATURING
Sheldon Litwin
- 1,079 views
- November 8, 2022
- 13
MUSC Cardiology
Lymphatic and Veins: The 2 Forgotten Vessels - The Future of HFpEF Therapeutics?
FEATURING
Marat Fudim
- 667 views
- November 8, 2022
- 10